comparemela.com

சிரியாக் அப்பி பிலிப்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Questions remain on DRDO s COVID drug

Questions remain on DRDO’s COVID drug Updated: Updated: May 12, 2021 08:33 IST Experts flag lack of published data on performance in human trials, history of drug’s use in cancer cure Share Article AAA On the frontline: A team of doctors and nurses at work in a COVID care centre near Ahmedabad.   Experts flag lack of published data on performance in human trials, history of drug’s use in cancer cure A drug developed by the Defence Research and Development Organisation (DRDO) and approved by the Drug Controller General of India (DCGI) for “emergency use” in those with moderate to severe COVID may soon make its way to hospitals for treating moderate and severely ill patients, but independent experts say that from the information so far available, the drug s utility in COVID care has not been established.

After legal threats from Herbalife, Elsevier journal retracts — and then removes

Paper about Herbalife®-related patient death removed after company threatens to sue the journal

Paper about Herbalife®-related patient death removed after company threatens to sue the journal A paper describing the death of a young woman trying to lose weight by consuming Herbalife® products has been withdrawn after the company threatened to sue the journal. Herbalife and criticism Herbalife Nutrition develops and sells plant-based dietary supplements for weight loss. According to Wikipedia, 58 percent of their shakes, protein bars, teas, and other products are made in company-owned manufacturing facilities in the US and China, with the remainder manufactured by third-party contractors. In 2016 the FTC filed a complaint that the company was being run as a “pyramid scheme.” The complaint was settled for $200 million.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.